New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.

When you think of brain stimulating medtech, startups building wearables as therapeutics probably aren't the first thing that ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no longer in shortage after nearly two years. Pharmacies that sold ...

In the research, mice were fed a high-fat diet were injected with the compound AP39, which delivers hydrogen sulfide direct to mitochondria in cells The research concluded that the treatment ...

One of the downsides of treatments such as Ozempic or Mounjaro is that even though patients wind up losing weight, they also tend to shed muscle mass. Losing too much muscle mass can be a health risk ...

A pharmacist warns that off-brand Ozempic, Zepbound, and other weight loss products carry undisclosed risks for consumers.

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

Anxiety disorders — characterized by uneasiness, worry, and fear — can cause various symptoms that affect how you think and ...

If Medicare were to start covering popular weight loss drugs such as Wegovy and Zepbound, it could increase federal spending ...

You knew when we married that I wasn’t attracted to larger (fat) women.” Since then, I no longer respect or value him.

Thieves broke into a South Fulton pharmacy early Thursday morning, stealing thousands of dollars in medication.